The 3P Project: A new approach to developing better treatments for TB
The 3P Project is a new approach to developing affordable, effective new drug regimens to treat tuberculosis, an ancient disease that still kills 1.5 million people a year. New treatments are urgently needed, particularly for drug-resistant forms of the disease; today's drug regimens are lengthy, toxic, expensive and only about 50% effective.
The 3P Project uses an open collaborative approach to conduct drug research and development (R&D), and uses novel approaches to finance and coordinate the process.
What are the 3 "P"s? Watch this video to find out!
Ensuring a healthy pipeline: rethinking TB drug research and development
Push, pull and pool: accelerating innovation and access for new treatment regimens for TB with MSF’s ‘3P Proposal’
- - Push funding to finance R&D activities upfront (i.e. through grants);
- - Pull funding to incentivise R&D activities through the promise of financial rewards on the achievement of certain R&D objectives (i.e. through milestone prizes);
- - Pooling of data and intellectual property to ensure open collaborative research and to ensure fair licensing for competitive production of the final products.
5 articles related to "The 3P Project: A new approach to developing better treatments for TB"
Interventions Agenda Item 5 (a-d): Progress on implementing WHA 66.22; Blueprint, AMR GAP, UNHLP Agenda Item 5 (e): Policy Coherence in Health R&D Agenda Item 5 (k) : Discussion on future...
Events & Presentations – Last updated 02 May 2016
The United Nations Secretary-General Ban Ki-moon has convened a High-Level Panel on Access to Medicines “to review and assess proposals and recommend solutions for remedying the policy incoherence...
Statements, Speeches, Letters – Last updated 29 March 2016
Briefing – Last updated 22 January 2016
The ‘3P Project’ aims to rapidly deliver affordable, effective new regimens for TB through an open collaborative approach to conducting drug development and through novel approaches to financing...
Briefing – Last updated 29 March 2016
Grania Brigden, TB advisor to the MSF Campaign for Access to Essential Medicines, describes how the current drug R&D model is failing TB patients. At last week’s Union World Conference...
Op-eds & Articles – Last updated 10 April 2015